Choose your location to get a site experience tailored for you.

Remember my region and language settings

A Beverage Divestiture

GlaxoSmithKline chose to divest two iconic consumer drink brands because the company was increasingly focusing its core health operations on emerging markets in which the two brands were relatively weak. The divestiture also helped streamline the company’s late-stage pipeline of pharmaceuticals and vaccines.

Read more impact stories

M&A and Divestitures

EN